tiprankstipranks

Renalytix AI’s KidneyIntelX™ Endorsed in KDIGO Guidelines

Renalytix AI’s KidneyIntelX™ Endorsed in KDIGO Guidelines

Confident Investing Starts Here:

An update from Renalytix AI (RNLX) is now available.

Renalytix plc announced that its KidneyIntelX™ product has been included in the final 2024 KDIGO guidelines for Chronic Kidney Disease, marking a significant endorsement from the medical community. This inclusion is not just a milestone for the company but also an important development for investors to watch, as it showcases the product’s growing recognition and potential impact on Renalytix’s market position.

See more data about RNLX stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App